These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 33527196)

  • 1. CD30
    Lam JH; Hong M; Koo SL; Chua CWL; Lim KL; Wee F; Wan WK; Leow WQ; Yeo JG; Tan IBH; Yeong J; Lim TKH; Lim TS
    Cancer Immunol Immunother; 2021 Aug; 70(8):2353-2365. PubMed ID: 33527196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNF optimally activatives regulatory T cells by inducing TNF receptor superfamily members TNFR2, 4-1BB and OX40.
    Hamano R; Huang J; Yoshimura T; Oppenheim JJ; Chen X
    Eur J Immunol; 2011 Jul; 41(7):2010-20. PubMed ID: 21491419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen-specific Tregs control T cell responses against a limited repertoire of tumor antigens in patients with colorectal carcinoma.
    Bonertz A; Weitz J; Pietsch DH; Rahbari NN; Schlude C; Ge Y; Juenger S; Vlodavsky I; Khazaie K; Jaeger D; Reissfelder C; Antolovic D; Aigner M; Koch M; Beckhove P
    J Clin Invest; 2009 Nov; 119(11):3311-21. PubMed ID: 19809157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic depletion of CCR8
    Van Damme H; Dombrecht B; Kiss M; Roose H; Allen E; Van Overmeire E; Kancheva D; Martens L; Murgaski A; Bardet PMR; Blancke G; Jans M; Bolli E; Martins MS; Elkrim Y; Dooley J; Boon L; Schwarze JK; Tacke F; Movahedi K; Vandamme N; Neyns B; Ocak S; Scheyltjens I; Vereecke L; Nana FA; Merchiers P; Laoui D; Van Ginderachter JA
    J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33589525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTLA-4 blockade drives loss of T
    Zappasodi R; Serganova I; Cohen IJ; Maeda M; Shindo M; Senbabaoglu Y; Watson MJ; Leftin A; Maniyar R; Verma S; Lubin M; Ko M; Mane MM; Zhong H; Liu C; Ghosh A; Abu-Akeel M; Ackerstaff E; Koutcher JA; Ho PC; Delgoffe GM; Blasberg R; Wolchok JD; Merghoub T
    Nature; 2021 Mar; 591(7851):652-658. PubMed ID: 33588426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addition of anti-TIM3 or anti-TIGIT Antibodies to anti-PD1 Blockade Augments Human T cell Adoptive Cell Transfer.
    Martinez M; Kim S; St Jean N; O'Brien S; Lian L; Sun J; Verona RI; Moon E
    Oncoimmunology; 2021 Jan; 10(1):1873607. PubMed ID: 33537176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of storage time and temperature on highly multiparametric flow analysis of peripheral blood samples; implications for clinical trial samples.
    Jerram A; Guy TV; Beutler L; Gunasegaran B; Sluyter R; Fazekas de St Groth B; McGuire HM
    Biosci Rep; 2021 Feb; 41(2):. PubMed ID: 33600563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced anti-tumor efficacy of IL-7/CCL19-producing human CAR-T cells in orthotopic and patient-derived xenograft tumor models.
    Goto S; Sakoda Y; Adachi K; Sekido Y; Yano S; Eto M; Tamada K
    Cancer Immunol Immunother; 2021 Sep; 70(9):2503-2515. PubMed ID: 33559069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine phosphatase SHP2 inhibitors in tumor-targeted therapies.
    Song Z; Wang M; Ge Y; Chen XP; Xu Z; Sun Y; Xiong XF
    Acta Pharm Sin B; 2021 Jan; 11(1):13-29. PubMed ID: 33532178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cells.
    Duhen R; Ballesteros-Merino C; Frye AK; Tran E; Rajamanickam V; Chang SC; Koguchi Y; Bifulco CB; Bernard B; Leidner RS; Curti BD; Fox BA; Urba WJ; Bell RB; Weinberg AD
    Nat Commun; 2021 Feb; 12(1):1047. PubMed ID: 33594075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCR8 Signaling
    Kang L; Schmalzl A; Leupold T; Gonzalez-Acera M; Atreya R; Neurath MF; Becker C; Wirtz S
    Front Immunol; 2020; 11():609400. PubMed ID: 33613532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of apatinib in recurrent/metastatic nasopharyngeal carcinoma: A pilot study.
    Huang L; Zhang X; Bai Y; Chua KLM; Xie Y; Shu X; Long B; Fan C; Lim DWT; Tan SH; Wee JTS; Wang Y; Wu Y; Chua MLK
    Oral Oncol; 2021 Apr; 115():105222. PubMed ID: 33610004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an Oncogenic Driver Alteration Associated Immune-Related Prognostic Model for Stage I-II Lung Adenocarcinoma.
    Xu JZ; Gong C; Xie ZF; Zhao H
    Front Oncol; 2020; 10():593022. PubMed ID: 33585210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CC Chemokine Receptors in Lung Adenocarcinoma: The Inflammation-Related Prognostic Biomarkers and Immunotherapeutic Targets.
    Liu F; Wu H
    J Inflamm Res; 2021; 14():267-285. PubMed ID: 33574689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computer-aided design of PVR mutants with enhanced binding affinity to TIGIT.
    Zhou X; Du J; Zhou X; Niu X; Li W; Chen C; Lv S; Wu A; Gou S; Sun Y; Zhai W; Qiu L; Qi Y; Zhao W; Gao Y
    Cell Commun Signal; 2021 Feb; 19(1):12. PubMed ID: 33557880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fc-Optimized Anti-CCR8 Antibody Depletes Regulatory T Cells in Human Tumor Models.
    Campbell JR; McDonald BR; Mesko PB; Siemers NO; Singh PB; Selby M; Sproul TW; Korman AJ; Vlach LM; Houser J; Sambanthamoorthy S; Lu K; Hatcher SV; Lohre J; Jain R; Lan RY
    Cancer Res; 2021 Jun; 81(11):2983-2994. PubMed ID: 33757978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systems biology analysis identifies
    Cho JW; Son J; Ha SJ; Lee I
    Comput Struct Biotechnol J; 2021; 19():860-868. PubMed ID: 33598101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell immunoglobulin and ITIM domain, as a potential immune checkpoint target for immunotherapy of colorectal cancer.
    Fathi M; Pustokhina I; Kuznetsov SV; Khayrullin M; Hojjat-Farsangi M; Karpisheh V; Jalili A; Jadidi-Niaragh F
    IUBMB Life; 2021 May; 73(5):726-738. PubMed ID: 33686787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of chimeric antigen receptors containing CD28 versus 4-1BB costimulatory domains.
    Cappell KM; Kochenderfer JN
    Nat Rev Clin Oncol; 2021 Nov; 18(11):715-727. PubMed ID: 34230645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. To Go or Not to Go?-Targeting Tregs Traveling in Tumors.
    Chakraborty S; Zappasodi R
    Cancer Res; 2021 Jun; 81(11):2817-2819. PubMed ID: 34087782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.